DK1768748T3 - Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf - Google Patents

Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf

Info

Publication number: DK1768748T3
Authority: DK; Denmark
Prior art keywords: strontium; vitamin; compositions; pharmaceutical composition; relates
Prior art date: 2004-06-25

Application number

DK05750580.2T

Other languages

English (en)

Other versions

DK1768748T4 (da

Inventor

John Nikolaj Hvarre Christensen

Original Assignee

Strontin Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-25

Filing date

2005-06-24

Publication date

2010-02-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34972075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1768748(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-24 Application filed by Strontin Aps filed Critical Strontin Aps

2010-02-01 Application granted granted Critical

2010-02-01 Publication of DK1768748T3 publication Critical patent/DK1768748T3/da

2019-06-11 Publication of DK1768748T4 publication Critical patent/DK1768748T4/da

Links

QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 3
229930003316 Vitamin D Natural products 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
235000019166 vitamin D Nutrition 0.000 title abstract 2
239000011710 vitamin D Substances 0.000 title abstract 2
229940046008 vitamin d Drugs 0.000 title abstract 2
229910052712 strontium Inorganic materials 0.000 title 1
CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title 1
150000003710 vitamin D derivatives Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 2
159000000008 strontium salts Chemical class 0.000 abstract 2
208000020084 Bone disease Diseases 0.000 abstract 1
208000001132 Osteoporosis Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002349 favourable effect Effects 0.000 abstract 1
BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
229910000018 strontium carbonate Inorganic materials 0.000 abstract 1
AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical class [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 abstract 1
-1 vitamin D compound Chemical class 0.000 abstract 1
235000005282 vitamin D3 Nutrition 0.000 abstract 1
239000011647 vitamin D3 Substances 0.000 abstract 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 1
229940021056 vitamin d3 Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Inorganic Chemistry (AREA)
Obesity (AREA)
Nutrition Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK05750580.2T 2004-06-25 2005-06-24 Sammensætninger omfattende strontium og vitamin D og anvendelser deraf DK1768748T4 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200400991		2004-06-25
DKPA200401733		2004-11-10
PCT/DK2005/000425 WO2006000224A2 (en)	2004-06-25	2005-06-24	Compositions comprising strontium and vitamin d and uses thereof

Publications (2)

Publication Number	Publication Date
DK1768748T3 true DK1768748T3 (da)	2010-02-01
DK1768748T4 DK1768748T4 (da)	2019-06-11

Family

ID=34972075

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05750580.2T DK1768748T4 (da)	2004-06-25	2005-06-24	Sammensætninger omfattende strontium og vitamin D og anvendelser deraf

Country Status (15)

Country	Link
US (1)	US8658206B2 (da)
EP (1)	EP1768748B2 (da)
JP (2)	JP5070046B2 (da)
KR (1)	KR20070034075A (da)
AT (1)	ATE443541T1 (da)
AU (1)	AU2005256317B2 (da)
BR (1)	BRPI0512357A (da)
CA (1)	CA2571449C (da)
DE (1)	DE602005016803D1 (da)
DK (1)	DK1768748T4 (da)
EA (1)	EA011814B1 (da)
IL (1)	IL180144A0 (da)
MX (1)	MXPA06015187A (da)
NO (1)	NO20070206L (da)
WO (1)	WO2006000224A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080118603A1 (en) *	2006-11-21	2008-05-22	Lada Mark W	Nutritional beverage for optimal bone health
WO2008061535A1 (en) *	2006-11-21	2008-05-29	Strontin Aps	Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases.
ES2573327T3 (es) *	2007-04-23	2016-06-07	Baxter International Inc.	Composiciones de fibrina que contienen compuestos de estroncio
WO2009010305A2 (en) *	2007-07-19	2009-01-22	Dsm Ip Assets B.V.	Tablettable formulations of lipophilic health ingredients
US8790714B2 (en)	2007-08-03	2014-07-29	Nucitec, S.A. De C.V.	Compositions and methods for treatment and prevention of osteoarthritis
EP2416756A2 (en) *	2009-04-10	2012-02-15	Mahmut Bilgic	Stable pharmaceutical compositions with high bioavailibility
FR2945748A1 (fr) *	2009-05-20	2010-11-26	Debregeas Et Associes Pharma	Medicament a base de calcium et de vitamine d.
FR2953139B1 (fr) *	2009-11-27	2012-04-13	Servier Lab	Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
EP2591354B1 (en) *	2010-07-07	2016-09-07	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
EP2590656B1 (en)	2010-07-07	2017-11-15	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
JP5827328B2 (ja)	2010-07-07	2015-12-02	アーデリクス，インコーポレーテッド	リン酸輸送を阻害する化合物及び方法
EP2590965B1 (en)	2010-07-07	2016-04-20	Ardelyx, Inc.	Compounds and methods for inhibiting phosphate transport
JP5827326B2 (ja)	2010-07-07	2015-12-02	アーデリクス，インコーポレーテッド	リン酸輸送を阻害する化合物及び方法
AU2012212385B2 (en) *	2011-02-02	2015-01-15	Ent Technologies Pty Ltd	Compositions and methods for the treatment of nasal passages
EP2530068A1 (en)	2011-05-31	2012-12-05	Lacer, S.A.	New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2014044756A1 (en) *	2012-09-20	2014-03-27	Mokwalo SA	Strontium as anti microbial compound

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3345265A (en) *	1963-10-09	1967-10-03	Kendall & Co	Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
US3699221A (en) *	1965-02-23	1972-10-17	Murray L Schole	Dental preparations
US3988434A (en)	1972-08-07	1976-10-26	Schole Murray L	Dental preparation
FR2633619B1 (fr)	1988-06-29	1991-02-08	Adir	Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr)	1989-09-01	1991-10-25	Adir	Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2658816A1 (fr) *	1990-02-27	1991-08-30	Adir	Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5380530A (en)	1992-12-29	1995-01-10	Whitehill Oral Technologies	Oral care composition coated gum
US5624906A (en) *	1994-12-08	1997-04-29	Lever Brothers Company, Division Of Conopco, Inc.	Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
FR2749759B1 (fr)	1996-06-17	1999-11-26	Adir	Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CN1164603C (zh)	2001-09-29	2004-09-01	南京化工大学	1，6－二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用
FR2844797B1 (fr)	2002-09-24	2004-10-22	Servier Lab	Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr)	2002-09-24	2004-03-26	Servier Lab	Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr)	2002-09-24	2004-10-22	Servier Lab	Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
PT1534305E (pt)	2003-05-07	2007-02-28	Osteologix As	Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt)	2003-05-07	2012-10-11	Osteologix As	Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20060216358A1 (en) *	2003-05-07	2006-09-28	Christian Hansen	Controlled release composition containing a strontium salt

2005
- 2005-06-24 DK DK05750580.2T patent/DK1768748T4/da active
- 2005-06-24 EP EP05750580.2A patent/EP1768748B2/en not_active Expired - Lifetime
- 2005-06-24 JP JP2007516973A patent/JP5070046B2/ja not_active Expired - Fee Related
- 2005-06-24 MX MXPA06015187A patent/MXPA06015187A/es not_active Application Discontinuation
- 2005-06-24 CA CA2571449A patent/CA2571449C/en not_active Expired - Fee Related
- 2005-06-24 EA EA200700130A patent/EA011814B1/ru active IP Right Revival
- 2005-06-24 AT AT05750580T patent/ATE443541T1/de not_active IP Right Cessation
- 2005-06-24 US US11/570,767 patent/US8658206B2/en not_active Expired - Fee Related
- 2005-06-24 AU AU2005256317A patent/AU2005256317B2/en not_active Ceased
- 2005-06-24 WO PCT/DK2005/000425 patent/WO2006000224A2/en not_active Ceased
- 2005-06-24 DE DE602005016803T patent/DE602005016803D1/de not_active Expired - Lifetime
- 2005-06-24 KR KR1020077001916A patent/KR20070034075A/ko not_active Withdrawn
- 2005-06-24 BR BRPI0512357-7A patent/BRPI0512357A/pt not_active IP Right Cessation
2006
- 2006-12-18 IL IL180144A patent/IL180144A0/en unknown
2007
- 2007-01-11 NO NO20070206A patent/NO20070206L/no not_active Application Discontinuation
2012
- 2012-07-13 JP JP2012157477A patent/JP2012193208A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
KR20070034075A (ko)	2007-03-27
EP1768748A2 (en)	2007-04-04
JP2012193208A (ja)	2012-10-11
HK1102427A1 (en)	2007-11-23
JP5070046B2 (ja)	2012-11-07
DK1768748T4 (da)	2019-06-11
EA011814B1 (ru)	2009-06-30
EP1768748B2 (en)	2019-03-13
CA2571449C (en)	2015-12-08
US8658206B2 (en)	2014-02-25
US20080026037A1 (en)	2008-01-31
WO2006000224A2 (en)	2006-01-05
CA2571449A1 (en)	2006-01-05
EA200700130A1 (ru)	2007-06-29
BRPI0512357A (pt)	2008-03-04
WO2006000224A3 (en)	2006-05-18
JP2008503504A (ja)	2008-02-07
NO20070206L (no)	2007-03-22
MXPA06015187A (es)	2007-09-27
DE602005016803D1 (de)	2009-11-05
EP1768748B1 (en)	2009-09-23
IL180144A0 (en)	2007-06-03
AU2005256317A1 (en)	2006-01-05
ATE443541T1 (de)	2009-10-15
AU2005256317B2 (en)	2011-09-15

Publication	Publication Date	Title
NO20070206L (no)	2007-03-22	Sammensetninger inneholdende strontium og vitamin D og anvendelser derav
NO2023022I1 (no)	2023-05-11	cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate
IN2012DN01233A (da)	2015-05-15
BRPI0520669A2 (pt)	2009-06-02	dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
IL193252A0 (en)	2009-02-11	N-hydroxyacrylamide compounds
SG146657A1 (en)	2008-10-30	Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
UA103930C2 (ru)	2013-12-10	Соединения и композиция для лечения паразитарных болезней
MXPA05011523A (es)	2006-01-23	Heteroarilos sustituidos como inhibidores de proteinas de tirosina fosfatasas.
TW200732296A (en)	2007-09-01	Novel compounds
TNSN08370A1 (en)	2009-12-29	Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2009013501A (es)	2010-01-18	Compuestos piperidinicos y sus usos.
TW200621313A (en)	2006-07-01	Pharmaceutical compositions
CY1113175T1 (el)	2016-04-13	Ενωση σουλφοναμιδης και εφαρμογη αυτης
EA201170512A1 (ru)	2011-08-30	Композиция для перорального введения
UY28774A1 (es)	2005-08-31	Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes.
TW200716204A (en)	2007-05-01	Pharmaceutical composition
TW200733961A (en)	2007-09-16	Diaryl urea for treating pulmonary hypertension
TW200716091A (en)	2007-05-01	New therapeutic combinations for the treatment or prevention of psychotic disorders
EA201170101A1 (ru)	2011-08-30	Фармацевтические композиции роувастатина кальция
EA200702282A1 (ru)	2008-02-28	Комбинация феррохина и производного артемизинина для лечения малярии
GB0524814D0 (en)	2006-01-11	Compounds
TW200800993A (en)	2008-01-01	Organic compounds
DK1784173T3 (da)	2012-05-07	Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
SI1893237T1 (sl)	2010-03-31	Farmacevtska zmes ki vsebuje organopolisiloksan elastomer in učinkovino v obliki raztopine
SE0203817D0 (sv)	2002-12-20	New composition